Showing results (1121-1130 of 1,458) with videos related to

Sort By:
Pageof 146
Pharmacogenetics and Genomics|April 13, 2007
Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancerSae-Won Han, Yoon Kyung Jeon, Kyung-Hun Lee, et al.
Plos One|December 17, 2015
Clinical Implication of Anti-Angiogenic Effect of Regorafenib in Metastatic Colorectal CancerYoojoo Lim, Sae-Won Han, Jeong Hee Yoon, et al.
Breast Cancer Research and Treatment|June 23, 2016
Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancerKoung Jin Suh, Han Suk Ryu, Kyung-Hun Lee, et al.
Investigational New Drugs|February 28, 2014
A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancerJeeyun Lee, Sang Joon Shin, Ik Joo Chung, et al.
Gut|January 21, 2021
Impaired antibacterial response of liver sinusoidal Vγ9<sup>+</sup>Vδ2<sup>+</sup> T cells in patients with chronic liver diseaseMin-Seok Rha, Ji Won Han, June-Young Koh, et al.
Cureus|March 18, 2024
Role of Portosystemic Shunt and Portal Vein Stent in Managing Portal Hypertension Due to Hematological DiseasesJi Hoon Kim, Suho Kim, Hee-Chul Nam, et al.
BMC Cancer|May 8, 2019
Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapyDae-Won Lee, Sae-Won Han, Yongjun Cha, et al.
Cancer Chemotherapy and Pharmacology|April 11, 2015
A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancerJin Won Kim, In Sil Choi, Yu Jung Kim, et al.
Science (New York, N.Y.)|February 21, 2012
Crystal structure of a lipid G protein-coupled receptorMichael A Hanson, Christopher B Roth, Euijung Jo, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 26, 2012
Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survivalEun Joo Kang, Seock-Ah Im, Do-Youn Oh, et al.
Pageof 146